09/25/2012—Plaintiffs Deborah Payne and Eric Nelson filed a Nuvaring Lawsuit, by and through their Nuvaring Lawyer, in the United States District Court of New Jersey recently. Plaintiff Deborah Payne utilized Nuvaring from approximately 2004 to October 23, 2010. On or about October 23, 2010, she suffered a bilateral pulmonary embolism. Her husband, Plaintiff Eric Nelson has been added to this Nuvaring Lawsuit because he alleges that he has lost the consortium of his wife, who will require continuing medical care as a result of her injuries.
Plaintiffs allege that Defendants marketed, promoted and advertised the ring product to physicians and to the public as equally or more safe than oral contraceptive pills even though Defendants knew that it was less safe. Plaintiffs further allege that Defendants marketed, promoted and advertised the ring product as presenting less of a risk of thrombotic side effects than other means of contraception because of its relatively low amount of estrogen in an attempt to disguise the fact that it had a high level of a dangerous third-generation progestin, capable of causing thrombotic side effects. Plaintiff also states that Defendants failed to warn prescribing physicians and the public that the ring product was associated with more thrombotic events than the pill.
Plaintiff goes on to state that Defendants failed to provide proper and full information as to safety to the Food and Drug Administration, which regulated the sale of the ring, and thereby avoided having appropriate warnings and cautions added to its labeling and advertising. Plaintiff asserts that Defendants obtained permission to market the ring product by presenting safety data derived from studies on the pill and failed to do proper clinical investigation with actual users of the ring product. Plaintiff alleges that in actuality, the ring product released a continuous stream of hormones (progestin and estrogen) into the body of the user at a higher level than in its promotional literature explained.
Plaintiff Deborah Payne alleges that Nuvaring is a defective product and that due to Defendants’ failure to warn consumers and medical providers of the risks associated with use of Nuvaring Defendants caused the injuries that Deborah Payne suffered. Had Ms. Payne known about the risks of using Nuvaring she would not have used the product and would not have been injured.
At this time we do not know if the Plaintiffs case will be added to the Nuvaring Multidistrict litigation or as it is more commonly called, the Nuvaring Class Action Lawsuit. Contact us for more information or to arrange a free legal consultation.